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Summary The value of DNA-flow cytometry and clinico-pathological prognostic factors for the prediction of
local recurrences after breast-conserving therapy (BCT) were evaluated in a retrospective study. Thirty-one
patients with a local recurrence were compared with 31 matched patients without a local recurrence.
Morphology and DNA-indices of the local recurrences and their corresponding primary tumours were
compared. Ductal carcinoma in situ was present significantly more often in the group with a primary recurring
tumour, than in the matched group (P<0.001), and the same holds for lobular carcinoma (n = 5). Half of the
tumours that recurred had macroscopically positive surgical margins compared to about one-fourth of the
matched group. Fifty-six per cent of the DNA-aneuploid stemlines in cases with local recurrence were present
in the corresponding primary tumour as well (confidence limits 45%-75%), an indication that the majority of
local recurrences are true recurrences and not independently developed tumours. The lack of similarlity of
DNA stemlines between some primary DNA-aneuploid tumours and their local recurrences indicates that
these tumours had developed independently. The percentage of DNA-aneuploid cases in the group with local
recurrence (89%) did not differ significantly from that in the matched group (70%). However, the findings
suggest a selective recurrence of DNA-diploid stemlines. This might indicate increased resistance of DNA-
diploid tumour cells to radiotherapy as compared with the resistance level in DNA-aneuploid cells.
Breast-conserving therapy (BCT) is being applied increasingly
in the primary treatment of early breast cancer (Eberlein et
al., 1990). One of the main concerns here is the continued
risk of local recurrence in the retained portion of a breast.
Unlike local recurrences after radical mastectomy, which
usually coincide with a systemic disease, most local recur-
rences after BCT can be adequately treated (Barr et al., 1989;
Cady, 1990). This means that follow up of patients treated by
BCT and identification of women at high risk of local recur-
rence development are essential. The question as to whether a
local recurrence itself constitutes a risk of developing distant
metastases remains to be answered. The published reports
indicate that a local recurrence does not significantly influ-
ence overall survival, but the number of follow-up years is
still small (Calle et al., 1986; Fisher et al., 1989).
A major goal for the improvement of BCT is the identi-
fication of patients, who are at increased risk of developing a
local recurrence. Important risk factors are the presence of a
large component of DCIS in the primary tumour (Dongen
van et al., 1989) and non-radical surgical margins (Kurtz et
al., 1990a). Whether the DNA content can contribute to
prediction of local recurrences has been the subject of only
one investigation (Cooke et al., 1988). In that study use was
made of DNA image cytometry and a positive association
was found between abnormal DNA content distribution and
the risk of local recurrence. In general, DNA-aneuploidy
determined by flow cytometry has been found in many
studies to be associated with a poorer prognosis for breast
cancer (Clark et al., 1989; Beerman et al., 1990). In the
present retrospective study we therefore assessed the value of
DNA-flow cytometry for the identification of patients at high
risk of local recurrence after BCT. Our results indicate that
DNA-flow cytometry does not promote this identification of
individual patients at high risk of local recurrence. Com-
parison of primary tumours and their local recurrences often
showed similarity in DNA-aneuploid stemlines, indicating
that a least 50% of local recurrences are true recurrences and
not independently developed tumours. Furthermore, our
results suggest a decreased sensitivity of DNA-diploid
tumour cells to radiotherapy.
Materials and methods
Patients
During the period between January 1980 and December
1988, 251 patients with primary breast carcinoma <3 cm
received similar treatment consisting of lumpectomy and
irradiation in the Leiden University Hospital (AZL), Leiden
(The Netherlands). Up to December 1989, 26 (10.4%) of
these patients had developed a local recurrence. For five
patients who had been treated at an affiliated general hospital
in Leiden and who developed a local recurrence, surgical
records, histological records, slides, and paraffin-embedded
material were available and were put at the disposal of the
Department of Pathology of the Leiden University Hospital.
All of the patients had received post-operative radiotherapy
of 50 Gy on the breast and a 15 Gy boost by electrons on the
tumour bed in the Department of Radiotherapy of the
Leiden University Hospital. The interval to local recurrence
was calculated as starting at the time of the primary surgical
treatment. Each patient with a local recurrence was matched
with another patient without a local recurrence, who had a
follow-up period similar to that of the disease-free period of
recurrent primary tumours. For 27 recurrent primary
tumours, 27 matched tumours, and 25 local recurrences,
enough tumour material was available to allow flow cyto-
metric analysis. The two cases of recurrence for which neither
histological examination nor flow cytometry was performed,
were diagnosed on the basis of the information supplied by
fine-needle aspiration. Patients were not matched for age. A
complete chronology of each patient's disease history includ-
ing data on initial treatment and follow-up was retrieved
from the Surgical Documenation Service (AZL). Patients
were staged according to the post-surgical TNM classification
(UICC). The average follow-up period, the patient's age (at
the time of diagnosis), TNM stage, tumour size, and nodal
status are listed in Table I.
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Histological classification
Histological sections of all of the tumours were reviewed
independently by two of the present authors (HB and MV).
The results of the macroscopical examination of surgical
margins were retrieved from the reports of the Department of
Pathology. For this retrospective investigation, inked micro-
scopical surgical margins were only available for a limited
number of cases and were not further evaluated.
Infiltrating ductal carcinomas with <75% DCIS were
graded according to a modified Bloom and Richardson class-
ification (Elston, 1987). With this method tubule formation
and nuclear pleomorphism are assessed and the mitotic rate
is determined. For all cases the fractional area of tumour
tissue of DCIS was independently estimated by two of the
authors (HB, MV) by visual examination of all available
histological slides. In case of a disagreement (> 10%), the
slides were re-examined until agreement was reached. On this
basis the infiltrating ductal carcinomas were assigned to one
of five categories according to the percentage of DCIS: 0%,
1-25%, 26-75%, 76-99%, and 100%. The DCIS were
classified according to their growth pattern as a comedo and
a non-comedo type and, according to their nuclear pleomor-
phism, as small or large type. This classification is simple and
seems to have a biological basis (van de Vijver et al., 1988;
Baird et al., 1990). Infiltrating ductal carcinomas with
>25% DCIS in the tumour were called ductal carcinomas
with an extensive intraductal component. Infiltrating lobular
carcinomas were not subdivided.
For histodiagnostic purposes, multiple tissue blocks were
routinely taken from different parts of the primary tumour
specimen and stored after being paraffin-embedded or frozen
at - 70C. For DNA flow cytometry, we retrieved all avail-
able tissue blocks from the archives of the Department of
Pathology.
DNA flow cytometry
The cell preparation and staining procedures used for fresh
and paraffin-embedded tissue have been described elsewhere
(Cornelisse et al., 1987). Briefly, suspensions of isolated
nuclei were prepared from fresh or frozen tissue specimens
according to Vindelov's detergent-trypsin procedure and were
stained with propidium iodide (Vindelov et al., 1983). Sam-
ples of deparaffinised tissue were stained with propidium
iodide. The DNA content was determined with an FACscan
flow cytometry (Becton Dickinson, San Jose, CA, USA) with
the appropriate filter combinations for the excitation and
measurements of PI. On average, about 10,000 cells per
sample were measured. Histological sections of frozen-tissue
and/or paraffin sections were cut from each tissue block to
permit estimation of the percentage of tumour cells, before
and after sectioning for flow cytometric analysis. The percen-
tage of tumour cells was estimated visually by two indepen-
dent observers (HB and CJC). If the estimated percentages
differed by more than 10%, the slides were re-examined in a
joint session until agreement was reached. All slides showing
less than 10%, or more than 90% tumour cells were con-
sidered unsuitable for flow cytometric analysis in paraffin-
embedded material. Rainbow trout red blood cells were
added to the suspensions of isolated nuclei prepared from the
frozen samples as an internal ploidy standard. For deparaffi-
nised samples this was not possible, and here non-neoplastic
cells in the tumour specimen (e.g. stroma cells and lympho-
cytes) served for internal ploidy control. The pepsin-digestion
technique was used to release nuclei from 45 tm sections of
paraffin-embedded tissue specimens (Hedley et al., 1983).
The average number of analysed samples of recurrent
primary tumours, matched,tumours, and local recurrences is
4.7 (s.d.
= 2.0), 3.7 (s.d.
= 1.1), and 3.7 (s.d.
= 1.0), respec-
tively. These numbers are fairly close to the minimal number
of four samples found in a previous study to be required to
adequately establish intra-tumour DNA-stemline hetero-
geneity (Beerman et al., 1991).
Table I Clinico-pathological variables and histological data on 31
primary tumours and 31 matched control tumours
Primary Matched
tumours tumours
n=31 n=31
Mean s.d. Mean s.d. Pa
Follow-up time (months) 34.4 (21.8) 35.7 (21.4)
Age (years) 46.7 (11.6) 47.2 (11.6) N.S.
Tumour size (mm) 23.1 (11.9) 21.0 ( 7.7) N.S.
Stage N.S.
0 6 0
II 8 14
IIA 9 12
IIB 5 2
Unknown 3 3
Tumour size N.S.
Tx 3 3
Tis 6 0
TI 12 14
T2 9 14
T3 1 0
Nodal status N.S.
NO 23 27
NI 8 4
Histology
Lobular carcinoma 5 0
Ductal carcinoma 26 31
Grade I 2 7 N.S.
Grade II 9 18 N.S.
Grade III 4 3 N.S.
Percentage DCIS
0 1 20 <0.01
<0-25 5 6 N.S.
<25- <100 14 5 <0.01
100 6 0 <0.05
Comedo type DCIS 19 7 <0.01
aMcNemar test applied topaired data. bOnly ductal carcinomas with
<75% DCIS were graded (n = 15).
Classification ofDNA-ploidy status
DNA profiles showing only one Go., cell population, with a
CV of < 5.5%, were classified as diploid, and those with one
or more additional Go., peaks as DNA-aneuploid. For frozen
samples, the position of the DNA-diploid peak was verified
with the use of the TRBC standard. In DNA profiles obtain-
ed in deparaffinised samples showing two or more distinct
Go., populations, the one at the extreme left was considered
to represent the non-neoplastic DNA-diploid cell population.
Tumours showing a single Go.I peak with a CV > 5.5% were
classified as 'wide CV DNA-diploid'. These were pooled with
the other DNA-diploid tumours, whereas Go., peaks with CV
> 10% were considered non-evaluable. tumour ploidy was
expressed as the DNA index (Hiddemann et al., 1984). The
average CV for paraffin-embedded material amounted to 5.5
(s.d. = 1.8, range 2.5-9.6) and for frozen tumour samples to
3.0 (s.d. = 1.0, range 2.0-6.4).
Tumours showing two or more different DNA-aneuploid
stemlines, in the same or different samples, were classified as
multiploid. We considered two DNA-aneuploid stemlines to
be different, if both gave distinct Go., peaks in the same
DNA profile, or the DNA indices of different tumour sam-
ples differed by more than 10%. The term intra-tumour
heterogeneity covers not only multiploidy but also tumours
having a single DNA-diploid stemline as well as a DNA-
aneuploid stemline in two separate tumour samples. A DNA-
diploid Go., peak accompanied by a DNA-aneuploid Go.,
peak in the same DNA profile was not considered to repre-
sent a tumour DNA-stemline. A DNA-diploid tumour cell
population was identified by the presence of a single Go.,
peak in DNA profiles ofspecimens with an estimated tumour
cellularity greater than 20%.
Statistical analysis
Statistical analysis was performed with the BMDP and SSPS
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ploidy stemlines in recurrent primary tumours, matched
tumours, and local recurrences was compared by the Kolmo-
gorov-Smirnov test. The differences between recurrent pri-
mary tumours, matched tumours, and/or local recurrences in
relation to clinicopathological variables and flow cytometric
results were analysed by the McNemar test on paired data. P
values <0.05 were considered significant.
Results
Comparison ofrecurrent primary tumours and matched
tumours
Clinico-pathological variables Several morphological differ-
ences were found between tumours with and without a local
recurrence. In almost all (25/26) ductal-type recurrent pri-
mary tumours, a component of ductal carcinoma in situ was
present. This frequency is significantly higher than that found
for the matched tumours (11/26) (P< 0.01) (Table I). There
were also significantly more ductal carcinomas with more
than 25% DCIS in recurrent primary tumours than in
matched tumours (14/26 vs 5/26; P<0.01). In a paired com-
parison, DCIS of the comedo type were found to occur
significantly more frequently in tumours that recurred than in
the matched tumours. Among tumours the five locally recurr-
ing primary tumours were diagnosed as infiltrating lobular
carcinoma, whereas none of the matched tumours was
lobular. Tumours with local recurrences showing positive
macroscopical surgical margins more often than matched
tumours (16/31 vs 7/31) did. Age, nodal status, TNM stage,
tumour size, and histological grade did not differ significantly
between the two groups (Table I).
DNA-ploidy
DNA flow cytometry applied to 27 tumours that recurred
locally and the tumours in the 27 matched patients, showed a
high degree of intra-tumour DNA stemline heterogeneity for
both recurrent primary and matched tumours. The average
number of distinct tumour DNA-stemlines, including both
DNA-aneuploid and DNA-diploid tumour stemlines, was
similar for recurrent primary tumours (n = 2.1, s.d. = 1.0,
range 1-5) and matched tumours (n = 1.8, s.d. = 0.7, range
1-3). Of the recurrent primary tumours, 89% (24/27) showed
DNA-aneuploidy vs 70% (19/27) of the matched tumours,
but the paired comparison showed that these differences were
not statistically significant. There were no significant differ-
ences in the percentage of either low DNA-aneuploid (DNA-
index < 1.40) or high DNA-aneuploid (DNA-index > 1.40)
stemlines (Beerman et al., 1990) (Table II).
Comparison ofrecurrent primary tumours and local
recurrences
Clinico-pathological variables Recurrence-free intervals of
infiltrating lobular carcinoma and infiltrating ductal car-
cinoma did not differ significantly (43 months, s.d. = 16.4,
range 11-59 vs 34 months, s.d. = 22.4, range 4-88). The two
small cell type DCIS recurred much later than the four large
Table II DNA ploidy in primary tumours (PT), matched control
tumours (MT), and local recurrences (LR)
PT MCO LRa
n = 27 n =27 n = 25
DNA-diploid 3 8 9
DNA-aneuploid 24 19 16
DNA-diploid + DNA-aneuploidb 15 14 18
DNA-index >1.40 18 16 11
Multiploidy 10 11 4
aPaired comparison (McNemar) shows no statistically significant
differences between PT/MT and PT/LR. bDNAdiploid and DNA-
aneuploid tumour stemlines in separate samples of the same tumour.
cell type DCIS did (average 68.5 months vs 38.5 months). Of
the six recurrent primary tumours composed solely of DCIS,
only two were DCIS after recurrence, the other four showed
less than 25% DCIS in the presence of infiltrating ductal
carcinoma. In five cases of recurrent primary tumours with
>75% DCIS, four of the local recurrences showed only
infiltrating carcinoma, the others more than 75% DCIS.
DNA-ploidy The average number of distinct tumour DNA-
stemlines in local recurrences (1.5, s.d. = 0.6, range 1-3) was
significantly lower than that in the primary tumours of the
same patients (P = 0.01) (Table III). In 56% (9/16) of the
local recurrences with a DNA-aneuploid stemline the same
DNA-stemline could be traced in the primary tumour (con-
fidence limits 45%-75%). In a high percentage (18/25) of the
local recurrences a DNA-diploid tumour cell population was
identified and half of this group was purely DNA-diploid (in
the other nine cases also a distinct DNA-aneuploid stemline
was also found in a separate sample of the same tumour). In
the corresponding nine primary tumours only one was purely
DNA-diploid; in the other eight primary tumours (six had
both DNA-diploid and DNA-aneuploid stemlines and two
only DNA-aneuploid stemlines) (Table III).
Comparisons between the percentages of low aneuploid
(DNA-index < 1.40) and high aneuploid tumours (DNA-
index > 1.40) in primary tumours and their local recurrences
showed no statistically significantly differences.
The average recurrence-free interval for patients in whom
the primary tumour and local recurrence showed one or
more identical aneuploid DNA-stemlines was not signifi-
cantly shorter, than for those without such DNA-stemline
similarity (33.9 months, s.d. = 20.7, range 4-76 vs 49.4
months, s.d. = 25.1, range 17-88).
Discussion
Our results confirm an association between the presence of
an intraductal component, particularly of the comedo type,
and an increased risk of local recurrence. These findings are
in agreement with most of the reports in the literature (Lind-
Table III Comparativedata on DNAstemlines in 25primary tumours
and 25 local recurrences. For all cases, indentical DNA stemlines are
only presented once
Local recurrence Primary tumour
DNA-diploid (n = 9)
1.0 1.0
1.0 1.0 1.1
1.0 1.0 1.1
1.0 1.0 1.8
1.0 1.0 1.9
1.0 1.0 2.2
1.0 1.0 1.1 1.2
1.0 1.6 1.7 1.8 2.1
1.0 1.7
Presence of similar DNA-aneuploid stemlines (n = 9)
1.0 1.1 1.0 1.1 1.3
1.0 1.2 1.0 1.2
1.0 1.7 1.7
1.0 1.9 1.9
1.1 1.8 2.1 1.0 1.3 2.1
1.2 1.6 1.2 1.6 1.8
1.3 2.1 1.1 1.3 1.9 2.1 3.2
1.5 1.1 1.5
2.1 1.0 1.3 1.9 2.1 2.5
Absence of similar DNA-aneuploid stemlines (n = 7)
1.0 1.5 1.0 1.2
1.0 1.6 1.0 1.9
1.0 1.1 1.0
1.0 1.3 1.0
1.0 1.1 1.5 1.7
1.2 1.8 2.1
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ley et al., 1989; Baird et al., 1990; Locker et al., 1990). The
tendency of DCIS to be multifocal or multicentric in about
25-50% of the cases has been thought to be responsible for
the high local recurrence rate (Schwartz et al., 1980; Holland
et al., 1990). Furthermore, the shorter local recurrence-free
period in patients with a high-grade DCIS vs those with a
well-differentiated DCIS seen in the present study has already
been reported (Lagios et al., 1989). A distinctly high inci-
dence of infiltrating lobular carcinoma in the group with a
local recurrence may indicate a higher risk oflocal recurrence
for this group. However, consensus has not been reached in
the literature on this subject (Mate et al., 1986; du Toit et al.,
1989; Schnitt et al., 1989; van Limbergen et al., 1990). All
five of these cases of recurrent lobular carcinoma in our
study showed a remarkable similarity of the histological pic-
ture. These tumours were composed of multiple lobular car-
cinoma foci separated from each other by non-neoplastic
breast parenchyme, indicating a possible multifocality or
multicentricity. A higher local recurrence risk of this tumour
type might be accounted for by its often diffuse growth
pattern and lack of dominant or well-defined mass.
In the present study the local recurrence rate was not
significantly associated with age, tumour size, TNM stage,
histological grade, or nodal status. The small size of the
tumours in our series may have obscured such relationships;
even in larger-scale studies these correlations are still contro-
versial (Harris et al., 1985; Fisher et al., 1986; Lindley et al.,
1989; Locker et al., 1989; Kurtz et al., 1990b). In cases that
did recur, the tumour specimens had macroscopically positive
margins more often than those in the matched control group
did. Similar observations have been made in other studies
(Kurtz et al., 1990a).
The similarity between DNA-aneuploid stemlines in 56%
of local recurrences and primary tumours supports the
opinion that these local recurrences are true recurrences and
not independently developing tumours. The likelihood that
two independent tumours will have the same aneuploid
DNA-indices has been shown by a recent statistical analysis
to be very small (Smit et al., 1990). Sofar, the evidence
indicating true local recurrence has been based solely on the
similarity in histology and location in or adjacent to the
initial tumour bed (Clarke et al., 1985; Fisher et al., 1986).
However, in six cases no concordance was found for DNA-
aneuploid stemlines between local recurrences and primary
tumours, even after extensive sampling of both the recurrence
and the primary tumour. In these cases an independent,
multicentric origin of the primary tumour and local recur-
rence is feasible.
Although not statistically significant, our data suggest that
there may be some kind of association between DNA-aneu-
ploidy and an increased recurrence rate. This is in line with
the results presented to the EORTC In Situ Breast Cancer
Workshop in 1988 (Cooke et al., 1988). However, this rela-
tionship is complicated by our finding that among 22 patients
with DNA-aneuploid recurrent primary tumours there was a
relatively high percentage (36) of the recurrences showing a
purely DNA-diploid stemline. In six cases where primary
tumours showed both DNA-aneuploid and DNA-diploid
tumour stemlines, only the DNA-diploid stemlines recurred.
This might indicate that DNA-diploid tumour cell popula-
tions are more resistant to radiotherapy than DNA-aneu-
ploid populations are.
The high frequency of DNA-aneuploid stemlines in the
present series is similar to the 88% found in a DNA image
cytometry study of 26 cases of DCIS + micro-invasive car-
cinoma (Carpenter et al., 1987). Generally, the reported
percentage of DNA-aneuploidy in the literature is lower
(Kallioniemi et al., 1987; Clark et al., 1989). This divergence
might be due to undersampling, since in the present study
(with extensive sampling) the calculated probability that a
single sample will be DNA-aneuploidy was only 64.9%,
which is well within the range reported in the literature.
Similar results for DNA-aneuploidy were obtained in a
recent flow-cytometric study on tumour heterogeneity (Beer-
man et al., 1991). Furthermore, the frequent coexistence of
DNA-diploid and DNA-aneuploid tumour cell populations
in our series of tumours might be attributable to the presence
of a DCIS component in most of the recent primary
tumours. DCIS are more frequently DNA-diploid, especially
the non-comedo type, than infiltrating carcinomas are (Car-
penter et al., 1987; Locker et al., 1990).
In sum, the present results confirm the conclusion that
there is higher risk of local recurrence for tumours with an
extensive intra-ductal component, and also indicate a higher
risk for infiltrating lobular carcinomas. The findings also
support the importance of macroscopically free surgical mar-
gins, and do not definite proof that DNA-aneuploidy consti-
tutes a major risk factor for local recurrence after BCT. The
higher incidence of DNA-diploid stemlines among cases of
local recurrence raises important questions about the sen-
sitivity of DNA-diploid tumour cell populations to radio-
therapy. Moreover, the concordance in DNA-aneuploidy
between primary tumours and local recurrences in more than
50% of the cases supports the notion that a substantial
proportion of local recurrences can be attributed to the
non-radical excision of tumour tissue.
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